This comprehensive guide is designed to demystify the FDA Category 2 peptide changes coming in 2026, focusing on what these updates mean for patients currently utilizing or considering therapies involving BPC-157, TB-500, KPV, MOTs-c, and GHK-Cu
These are what our team considers hard stops based on the current body of scientific evidence and a deep understanding of the peptide's mechanism of action
Step 3: Draw the bacteriostatic water Using a fresh, sterile syringe, insert the needle through the rubber stopper of the bacteriostatic water vial
WARNINGS Benzyl alcohol Local pickup and support #102-32883 South Fraser Way, Abbotsford, BC V2S 2A6 +1 604 853 1101 [email protected] Serving Abbotsford and the Fraser Valley with support across British Columbia
Dihexa remains an investigational compound and is not FDA-approved for medical use